DoctorsAndrew A. Moshfeghi, MD, MBA

Andrew A. Moshfeghi, MD, MBA

Title: Associate Professor of Clinical Ophthalmology, Director of Clinical Trials and Director of the Medical Retina Fellowship Program

Department: Ophthalmology

Clinical Specialty: Vitreoretinal Surgery and Medical Retina Disease

Treatment Expertise: Macular Degeneration, Diabetic Eye Disease, Retinal Detachment, Macular Hole, Macular Pucker (Epiretinal membrane)

Certification: American Board of Ophthalmology

Language: English, Conversational Spanish

Location: Los Angeles and Pasadena

Biography and Education

Biography

Andrew A. Moshfeghi, MD, MBA, earned his medical degree from Tulane University School of Medicine in 1999. Following completion of his residency in ophthalmology, Dr. Moshfeghi attended the prestigious Bascom Palmer Eye Institute for his fellowship training in medial retina and vitreoretinal surgery and diseases. He also graduated from the University of Miami Graduate School of Business Administration with an MBA specializing in Health Sector Policy and Management.

Dr. Andrew A. Moshfeghi serves as an associate professor of clinical ophthalmology, director of Clinical Trials, and director of the Medical Retina Fellowship Program at USC. He is a recognized expert in diseases of the vitreous, retina, and macula. He formerly served as associate professor of Ophthalmology and medical director at the Bascom Palmer Eye Institute at the University of Miami. Dr. Moshfeghi is a noted vitreoretinal surgeon.

Research Interests:

Dr. Moshfeghi’s research concentrates on evaluation of intraocular pharmacotherapeutics, application of novel ophthalmic imaging techniques, and assessing health care utilization trends.

See Dr. Moshfeghi discuss the effect of L-DOPA on timing of AMD onset.

Education

  • MD, Tulane University School of Medicine, 1999
  • MBA, University of Miami Graduate School of Business Administration; Health Sector Policy and Management, 2009

Internship

  • MetroWest Medical Center/Harvard Medical School Transitional Internship (TRANSITIONAL INTERNSHIP: Framingham, MA, 1999 – 2000)

Residency

  • North Shore University Hospital – Long Island Jewish Health System/NYU School of Medicine, Manhasset, NY, 2000 – 2003

Fellowship

  • Bascom Palmer Eye Institute, Medical Retina Fellowship: Miami, Florida, 2003 – 2004
  • Bascom Palmer Eye Institute, Vitreoretinal Surgery & Diseases Retina Fellowship: Miami, Florida, 2004 – 2006

Accomplishments

Professional society memberships

  • American Academy of Ophthalmology
  • American Society of Retina Specialists
  • American Society for Research in Vision and Ophthalmology (ARVO)
  • The Macula Society
  • The Retina Society
  • Vit Buckle Society (Founding Member and Permanent Board Member)
  • The CONNECT Network (Founding Member and Permanent Board Member)
  • Club Vit

Awards

  • The University of Chicago Small School Talent Search Scholar, 1991-1995
  • Tulane University School of Medicine James H. Allen Award for Excellence in Ophthalmology, 1998-1999
  • Ronald G. Michels Fellowship Foundation Award, 2005
  • Full-Tuition Competitive Scholarship for Executive MBA 2007-2009, University of Miami School of Business Administration Program in Health Sector Policy & Management
  • “Florida Super Doctor” Award, 2009
  • University of Miami Graduate School of Business Administration, Executive MBA Program in Health Sector Policy & Management Award of Academic Merit (Honors Equivalent) 2009
  • Named a “Best Doctor in America” 2009, 2010
  • Inducted into Beta Gamma Sigma Academic Honor Society 2010, University of Miami Graduate School of Business Administration
  • Dame Celia Lipton Farris and Victor Farris Foundation 2012 Philanthropic Research Awardee ($1,000,000.00)
  • “Boca Raton Super Doctor” Award, 2013
  • American Academy of Ophthalmology Achievement Award, 2013
  • “Best Doctors” Awardee, 2009-2014
  • Castle Connolly “Top Doctors” Awardee, 2012 – 2014
  • American Society of Retina Specialists (ASRS) Honor Award, 2015
  • Best Presentation from Posterior Segment Specialty Meetings 2015” by the American Academy of Ophthalmology & American Society of Retina Specialists, 2015
  • Best Doctors in America, 2015 – 2016

Publications

  1. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, Gregori G, Penha FM, Moshfeghi AA, et al. Comparison of Geographic Atrophy Growth Rates Using Different Imaging Modalities in the COMPLETE Study. Ophthalmic Surgery, Lasers & Imaging Retina. 2015;46(4):413-22. Epub 2015/05/15. doi: 10.3928/23258160-20150422-03. PubMed PMID: 25970861.
  2. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, Gregori G, Penha FM, Moshfeghi AA, et al. Association Between Growth of Geographic Atrophy and the Complement Factor I Locus. Ophthalmic Surgery, Lasers & Imaging Retina. 2015;46(7):772-4. Epub 2015/08/08. doi: 10.3928/23258160-20150730-15. PubMed PMID: 26247461.
  3. Witkin AJ, Shah AR, Engstrom RE, Kron-Gray MM, Baumal CR, Johnson MW, et al. Postoperative Hemorrhagic Occlusive Retinal Vasculitis: Expanding the Clinical Spectrum and Possible Association with Vancomycin. Ophthalmology. 2015;122(7):1438-51. Epub 2015/04/19. doi: 10.1016/j.ophtha.2015.03.016. PubMed PMID: 25886796.
  4. Vaziri K, Schwartz SG, Kishor KS, Fortun JA, Moshfeghi DM, Moshfeghi AA, et al. Incidence of Postoperative Suprachoroidal Hemorrhage After Glaucoma Filtration Surgeries in the United States. Clinical Ophthalmology (Auckland, NZ). 2015;9:579-84. Epub 2015/04/22. doi: 10.2147/opth.s78359. PubMed PMID: 25897196; PubMed Central PMCID: PMCPmc4396511.
  5. Vaziri K, Pershing S, Albini TA, Moshfeghi DM, Moshfeghi AA. Risk Factors Predictive of Endogenous Endophthalmitis among Hospitalized Patients with Hematogenous Infections in the United States. American Journal of Ophthalmology. 2015;159(3):498-504. Epub 2014/12/09. doi: 10.1016/j.ajo.2014.11.032. PubMed PMID: 25486541.
  6. Vaziri K, Moshfeghi DM, Moshfeghi AA. Feasibility of Telemedicine in Detecting Diabetic Retinopathy and Age-Related Macular Degeneration. Seminars in Ophthalmology. 2015;30(2):81-95. Epub 2013/11/01. doi: 10.3109/08820538.2013.825727. PubMed PMID: 24171781.
  7. Vaziri K, Moshfeghi DM, Hernandez-Boussard T, Callaway NF, Moshfeghi AA. Ambulatory Surgery Center Utilization by Vitreoretinal Surgeons: 1999-2011. Ophthalmic Surgery, Lasers & Imaging Retina. 2015;46(3):355-61. Epub 2015/04/10. doi: 10.3928/23258160-20150323-10. PubMed PMID: 25856823.
  8. Vaziri K, Kishor K, Schwartz SG, Maharaj AS, Moshfeghi DM, Moshfeghi AA, et al. Incidence of Bleb-Associated Endophthalmitis in the United States. Clinical Ophthalmology (Auckland, NZ). 2015;9:317-22. Epub 2015/02/25. doi: 10.2147/opth.s75286. PubMed PMID: 25709395; PubMed Central PMCID: PMCPmc4334336.
  9. Pershing S, Vaziri K, Albini TA, Moshfeghi DM, Moshfeghi AA. Reply. American Journal of Ophthalmology. 2015;160(2):392. Epub 2015/07/19. doi: 10.1016/j.ajo.2015.04.037. PubMed PMID: 26187878.
  10. Gregori NZ, Flynn HW, Jr., Schwartz SG, Rosenfeld PJ, Vaziri K, Moshfeghi AA, et al. Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment. Ophthalmic Surgery, Lasers & Imaging Retina. 2015;46(6):643-8. Epub 2015/06/27. doi: 10.3928/23258160-20150610-08. PubMed PMID: 26114845.
  11. Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP, Gregori G, Penha FM, Moshfeghi AA, et al. Systemic Complement Inhibition with Eculizumab for Geographic Atrophy in Age-Related Macular Degeneration: The COMPLETE Study. Ophthalmology. 2014;121(3):693-701. Epub 2013/12/03. doi: 10.1016/j.ophtha.2013.09.044. PubMed PMID: 24289920; PubMed Central PMCID: PMCPmc4015213.
  12. Nicholson LB, Kim BT, Jardon J, Townsend-Pico W, Santos C, Moshfeghi AA, et al. Severe Bilateral Ischemic Retinal Vasculitis following Cataract Surgery. Ophthalmic Surgery, Lasers & Imaging Retina. 2014;45(4):338-42. Epub 2014/08/16. doi: 10.3928/23258160-20140605-01. PubMed PMID: 25127533.
  13. Garcia Filho CA, Yehoshua Z, Gregori G, Nunes RP, Penha FM, Moshfeghi AA, et al. Change in Drusen Volume as a Novel Clinical Trial Endpoint for the Study of Complement Inhibition in Age-Related Macular Degeneration. Ophthalmic Surgery, Lasers & Imaging Retina. 2014;45(1):18-31. Epub 2013/12/21. doi: 10.3928/23258160-20131217-01. PubMed PMID: 24354307.
  14. Cabrera M, Gonzalez A, Albini TA, Rowaan C, Aguilar M, Lee W, et al. Differential Flow Rate of Commercially Available Triamcinolone with and without Preservative Through Small-Gauge Needles. Ophthalmic Surgery, Lasers & Imaging Retina. 2014;45(1):54-7. Epub 2014/01/08. doi: 10.3928/23258160-20131220-08. PubMed PMID: 24392913.
  15. Vaziri K, Moshfeghi AA, Moshfeghi DM. Fundus Findings in Chronic Granulomatous Disease. Ophthalmic Surgery, Lasers & Imaging Retina. 2013;44(4):390-2. Epub 2013/06/27. doi: 10.3928/23258160-20130601-01. PubMed PMID: 23799791.
  16. Nunes RP, Gregori G, Yehoshua Z, Stetson PF, Feuer W, Moshfeghi AA, et al. Predicting the Progression of Geographic Atrophy in Age-Related Macular Degeneration with SD-OCT en Face Imaging of the Outer Retina. Ophthalmic Surgery, Lasers & Imaging Retina. 2013;44(4):344-59. Epub 2013/07/26. doi: 10.3928/23258160-20130715-06. PubMed PMID: 23883530.
  17. Moshfeghi AA. Eight Questions with Dr. Puliafito. Ophthalmic Surgery, Lasers & Imaging Retina. 2013;44(1):103-4. Epub 2013/02/16. doi: 10.3928/23258160-20130103-03. PubMed PMID: 23410818.
  18. Morales-Canton V, Quiroz-Mercado H, Velez-Montoya R, Zavala-Ayala A, Moshfeghi AA, Shusterman EM, et al. 16 and 24 Gy Low-Voltage X-Ray Irradiation with Ranibizumab Therapy for Neovascular Age-Related Macular Degeneration: 12-Month Outcomes. American Journal of Ophthalmology. 2013;155(6):1000-8.e2. Epub 2013/03/19. doi: 10.1016/j.ajo.2013.01.015. PubMed PMID: 23497847.
  19. Kim BT, Schwartz SG, Smiddy WE, Doshi RR, Kovach JL, Berrocal AM, et al. Initial Outcomes following Intravitreal Ocriplasmin for Treatment of Symptomatic Vitreomacular Adhesion. Ophthalmic Surgery, lasers & Imaging Retina. 2013;44(4):334-43. Epub 2013/07/26. doi: 10.3928/23258160-20130715-05. PubMed PMID: 23883268.
  20. Fijalkowski N, Zheng LL, Henderson MT, Moshfeghi AA, Maltenfort M, Moshfeghi DM. Academic Productivity and its Relationship to Physician Salaries in the University of California Healthcare System. Southern Medical Journal. 2013;106(7):415-21. Epub 2013/07/04. doi: 10.1097/SMJ.0b013e31829b9dae. PubMed PMID: 23820322.
  21. Duker JS, Moshfeghi AA. Ocriplasmin: A Medical or Surgical Therapy? Retina (Philadelphia, Pa). 2013;33(10):2001-2. Epub 2013/10/12. doi: 10.1097/iae.0000000000000016. PubMed PMID: 24113274.
  22. Yeh S, Albini TA, Moshfeghi AA, Nussenblatt RB. Uveitis, the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT), and Intravitreal Biologics for Ocular Inflammation. American Journal of Ophthalmology. 2012;154(3):429-35.e2. Epub 2012/08/18. doi: 10.1016/j.ajo.2012.05.011. PubMed PMID: 22898344; PubMed Central PMCID: PMCPmc3422772.
  23. Moshfeghi AA, Morales-Canton V, Quiroz-Mercado H, Velez-Montoya R, Zavala-Ayala A, Shusterman EM, et al. 16 Gy Low-Voltage X-Ray Irradiation Followed by as Needed Ranibizumab Therapy for Age-Related Macular Degeneration: 12 Month Outcomes of a ‘Radiation-First’ Strategy. The British Journal of Ophthalmology. 2012;96(10):1320-4. Epub 2012/08/17. doi: 10.1136/bjophthalmol-2011-301222. PubMed PMID: 22895887.
  24. Leng T, Jaben KA, Zheng L, Yang J, Paulus YM, Moshfeghi AA, et al. The Influence of Medical School and Residency Training Program Upon Choice of an Academic Career and Academic Productivity Among Otolaryngology Faculty in the United States of America: Our Experience of 1433 Academic Otolaryngologists. Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2012;37(1):58-62. Epub 2012/03/22. doi: 10.1111/j.1749-4486.2011.02402.x. PubMed PMID: 22433138.
  25. Canton VM, Quiroz-Mercado H, Velez-Montoya R, Lopez-Miranda MJ, Moshfeghi AA, Shusterman EM, et al. 24-Gy Low-Voltage X-Ray Irradiation with Ranibizumab Therapy for Neovascular AMD: 6-Month Safety and Functional Outcomes. Ophthalmic Surgery, Lasers & Imaging : The Official Journal of the International Society for Imaging in the Eye. 2012;43(1):20-4. Epub 2012/01/19. doi: 10.3928/15428877-20111129-01. PubMed PMID: 22251841.
  26. Thayil SM, Albini TA, Nazari H, Moshfeghi AA, Parel JM, Rao NA, et al. Local Ischemia and Increased Expression of Vascular Endothelial Growth Factor Following Ocular Dissemination of Mycobacterium Tuberculosis. PloS One. 2011;6(12):e28383. Epub 2011/12/14. doi: 10.1371/journal.pone.0028383. PubMed PMID: 22162767; PubMed Central PMCID: PMCPmc3230586.
  27. Silva RA, Moshfeghi AA, Kaiser PK, Singh RP, Moshfeghi DM. Radiation Treatment for Age-Related Macular Degeneration. Seminars in Ophthalmology. 2011;26(3):121-30. Epub 2011/05/26. doi: 10.3109/08820538.2011.554486. PubMed PMID: 21609224.
  28. Moshfeghi AA, Rosenfeld PJ, Flynn HW, Jr., Schwartz SG, Davis JL, Murray TG, et al. Endophthalmitis after Intravitreal Vascular [corrected] Endothelial Growth Factor Antagonists: A Six-Year Experience at a University Referral Center. Retina (Philadelphia, Pa). 2011;31(4):662-8. Epub 2011/08/13. doi: 10.1097/IAE.0b013e31821067c4. PubMed PMID: 21836400.
  29. Moshfeghi AA, Charalel RA, Hernandez-Boussard T, Morton JM, Moshfeghi DM. Declining Incidence of Neonatal Endophthalmitis in the United States. American Journal of Ophthalmology. 2011;151(1):59-65.e1. Epub 2010/10/26. doi: 10.1016/j.ajo.2010.07.008. PubMed PMID: 20970776.
  30. Moshfeghi AA, Canton VM, Quiroz-Mercado H, Velez-Montoya R, Lopez-Miranda MJ, Shusterman EM, et al. 16-Gy Low-Voltage X-Ray Irradiation Followed by As-Needed Ranibizumab Therapy for AMD: 6-Month Outcomes of a “Radiation-First” Strategy. Ophthalmic Surgery, Lasers & Imaging : The Official Journal of the International Society for Imaging in the Eye. 2011;42(6):460-7. Epub 2011/08/13. doi: 10.3928/15428877-20110804-03. PubMed PMID: 21830745.
  31. Moshfeghi AA, Albini TA, Kitchens JW, Leng T, Moshfeghi DM. The Vitreous Trap: A Simple, Surgeon-Controlled Technique for Obtaining Undiluted Vitreous and Subretinal Specimens During Pars Plana Vitrectomy. Retina (Philadelphia, Pa). 2011;31(2):426-7; author reply 7. Epub 2011/01/15. doi: 10.1097/IAE.0b013e318200c125. PubMed PMID: 21233788.
  32. Moshfeghi AA. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Seminars in ophthalmology. 2011;26(3):139-48. Epub 2011/05/26. doi: 10.3109/08820538.2011.570847. PubMed PMID: 21609227.
  33. Canton VM, Quiroz-Mercado H, Velez-Montoya R, Lopez-Miranda MJ, Moshfeghi AA, Shusterman EM, et al. 16-Gy low-voltage x-ray irradiation with ranibizumab therapy for AMD: 6-month safety and functional outcomes. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye. 2011;42(6):468-73. Epub 2011/08/13. doi: 10.3928/15428877-20110804-01. PubMed PMID: 21830747.
  34. Campbell PG, Lee YH, Bell RD, Maltenfort MG, Moshfeghi DM, Leng T, et al. Medical school and residency influence on choice of an academic career and academic productivity among US neurology faculty. Archives of neurology. 2011;68(8):999-1004. Epub 2011/04/13. doi: 10.1001/archneurol.2011.67. PubMed PMID: 21482917.
  35. Campbell PG, Awe OO, Maltenfort MG, Moshfeghi DM, Leng T, Moshfeghi AA, et al. Medical school and residency influence on choice of an academic career and academic productivity among neurosurgery faculty in the United States. Clinical article. Journal of neurosurgery. 2011;115(2):380-6. Epub 2011/04/19. doi: 10.3171/2011.3.jns101176. PubMed PMID: 21495810.
  36. Tang J, Rivers MB, Moshfeghi AA, Flynn HW, Chan CC. Pathology of macular foveoschisis associated with degenerative myopia. Journal of ophthalmology. 2010;2010. Epub 2010/09/04. doi: 10.1155/2010/175613. PubMed PMID: 20814547; PubMed Central PMCID: PMCPmc2931386.
  37. Shirodkar AR, Flynn HW, Alliman K, Lalwani GA, Alabiad C, Moshfeghi AA, et al. The comparison of clinical outcomes of endophthalmitis from fluoroquinolone-resistant and susceptible bacteria. Clinical ophthalmology (Auckland, NZ). 2010;4:211-4. Epub 2010/05/14. PubMed PMID: 20463786; PubMed Central PMCID: PMCPmc2861925.
  38. Javey G, Schwartz SG, Moshfeghi AA, Asrani S, Flynn HW, Jr. Methicillin-resistant Staphylococcus epidermidis isolation from the vitrectomy specimen four hours after initial treatment with vancomycin and ceftazidime. Clinical ophthalmology (Auckland, NZ). 2010;4:101-4. Epub 2010/03/18. PubMed PMID: 20234775; PubMed Central PMCID: PMCPmc2835531.
  39. Javey G, Moshfeghi AN, Moshfeghi AA. Management of ruptured retinal arterial macroaneurysm with intravitreal bevacizumab. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye. 2010;41(4):1-5. Epub 2011/07/06. PubMed PMID: 21728252.
  40. Javey G, Albini TA, Moshfeghi AA, Kelly KT, Flynn HW, Jr. Spectral-domain optical coherence tomography appearance of preretinal aggregation of intravitreal antibiotics. Retina (Philadelphia, Pa). 2010;30(1):184-5. Epub 2009/12/10. doi: 10.1097/IAE.0b013e3181bfbdc9. PubMed PMID: 19996824.
  41. Cavalcante LL, Cavalcante ML, Murray TG, Vigoda MM, Pina Y, Decatur CL, et al. Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clinical ophthalmology (Auckland, NZ). 2010;4:519-24. Epub 2010/06/11. PubMed PMID: 20535228; PubMed Central PMCID: PMCPmc2879353.
  42. Moshfeghi AA, Nugent AK, Nomoto H, Sanislo SR, Kitchens JW, Moshfeghi DM. Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior. Retina (Philadelphia, Pa). 2009;29(5):689-98. Epub 2009/04/18. doi: 10.1097/IAE.0b013e31819e390a. PubMed PMID: 19373129.
  43. Jockovich ME, Murray TG, Clifford PD, Moshfeghi AA. Posterior juxtascleral injection of anecortave acetate: magnetic resonance and echographic imaging and localization in rabbit eyes. Retina (Philadelphia, Pa). 2007;27(2):247-52. Epub 2007/02/10. doi: 10.1097/01.iae.0000242853.80913.63. PubMed PMID: 17290209.
  44. Scott IU, Moshfeghi AA, Flynn HW, Jr. Surgical management of macular retinoschisis associated with high myopia. Archives of ophthalmology (Chicago, Ill : 1960). 2006;124(8):1197-9. Epub 2006/08/16. doi: 10.1001/archopht.124.8.1197. PubMed PMID: 16908827.
  45. Moshfeghi AA, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study. Ophthalmology. 2006;113(11):2002.e1-12. Epub 2006/10/10. doi: 10.1016/j.ophtha.2006.05.070. PubMed PMID: 17027972.
  46. Moshfeghi AA, Harrison SA, Reinstein DZ, Ferrone PJ. Valsalva-like retinopathy following hyperopic laser in situ keratomileusis. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye. 2006;37(6):486-8. Epub 2006/12/13. PubMed PMID: 17152544.
  47. Soheilian M, Feghi M, Yazdani S, Anisian A, Ahmadieh H, Dehghan MH, et al. Surgical management of non-metallic and non-magnetic metallic intraocular foreign bodies. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye. 2005;36(3):189-96. Epub 2005/06/17. PubMed PMID: 15957475.
  48. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye. 2005;36(4):331-5. Epub 2005/09/15. PubMed PMID: 16156152.
  49. Moshfeghi AA, Puliafito CA. Pegaptanib sodium for the treatment of neovascular age-related macular degeneration. Expert opinion on investigational drugs. 2005;14(5):671-82. Epub 2005/06/02. doi: 10.1517/13543784.14.5.671. PubMed PMID: 15926872.
  50. Moshfeghi AA, Peyman GA. Micro- and nanoparticulates. Advanced drug delivery reviews. 2005;57(14):2047-52. Epub 2005/11/22. doi: 10.1016/j.addr.2005.09.006. PubMed PMID: 16298454.
  51. Moshfeghi AA, Harrison SA, Ferrone PJ. Indocyanine green angiography findings in sympathetic ophthalmia. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye. 2005;36(2):163-6. Epub 2005/03/29. PubMed PMID: 15792321.
  52. Moshfeghi AA, Flynn HW, Jr., Elner SG, Puliafito CA, Gass JD. Persistent outer retinal defect after successful macular hole repair. American journal of ophthalmology. 2005;139(1):183-4. Epub 2005/01/18. doi: 10.1016/j.ajo.2004.06.082. PubMed PMID: 15652846.
  53. Kitchens JW, Flynn HW, Jr., Moshfeghi AA, Puliafito CA. Idiopathic macular hole with extensive subretinal fluid: clinical and optical coherence tomography features before and after surgery. American journal of ophthalmology. 2005;139(2):383-6. Epub 2005/03/01. doi: 10.1016/j.ajo.2004.08.030. PubMed PMID: 15734018.
  54. Soheilian M, Abolhasani A, Ahmadieh H, Azarmina M, Dehgan MH, Mashavekhi A, et al. Management of magnetic intravitreal foreign bodies in 71 eyes. Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye. 2004;35(5):372-8. Epub 2004/10/23. PubMed PMID: 15497547.
  55. Moshfeghi AA, Scott IU, Flynn HW, Jr., Puliafito CA. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. American journal of ophthalmology. 2004;138(3):489-92. Epub 2004/09/15. doi: 10.1016/j.ajo.2004.03.025. PubMed PMID: 15364241.
  56. Moshfeghi AA, Pendergast SD, Hartzer MK, Ferrone PJ. The effects of scleral buckling on young rabbit eyes. Archives of ophthalmology (Chicago, Ill : 1960). 2004;122(4):473-6. Epub 2004/04/14. doi: 10.1001/archopht.122.4.473. PubMed PMID: 15078663.
  57. Moshfeghi AA, Banach MJ, Salam GA, Ferrone PJ. Lens-sparing vitrectomy for progressive tractional retinal detachments associated with stage 4A retinopathy of prematurity. Archives of ophthalmology (Chicago, Ill : 1960). 2004;122(12):1816-8. Epub 2004/12/15. doi: 10.1001/archopht.122.12.1816. PubMed PMID: 15596585.
  58. Moshfeghi AA, Awner S, Salam GA, Ferrone PJ. Excellent visual outcome and reversal of dragging after lens sparing vitrectomy for progressive tractional stage 4a retinopathy of prematurity retinal detachment. Retina (Philadelphia, Pa). 2004;24(4):615-6. Epub 2004/08/10. PubMed PMID: 15300086.
  59. Peyman GA, Genaidy M, Yoneya S, Men G, Ghahramani F, Kuo PC, et al. Transpupillary thermotherapy threshold parameters: effect of indocyanine green pretreatment. Retina (Philadelphia, Pa). 2003;23(3):378-86. Epub 2003/06/26. PubMed PMID: 12824840.
  60. Moshfeghi AA, Salam GA, Deramo VA, Shakin EP, Ferrone PJ, Shakin JL, et al. Management of macular holes that develop after retinal detachment repair. American journal of ophthalmology. 2003;136(5):895-9. Epub 2003/11/05. PubMed PMID: 14597042.
  61. El-Dessouky ES, Moshfeghi AA, Peyman GA, Yoneya S, Mori K, Kazi AA, et al. Toxicity of the photosensitizer NPe6 following intravitreal injection. Ophthalmic surgery and lasers. 2001;32(4):316-21. Epub 2001/07/28. PubMed PMID: 11475398.
  62. Toth J, Karcioglu ZA, Moshfeghi AA, Issa TM, Al-Ma’ani JR, Patel KV. The relationship between human papillomavirus and p53 gene in conjunctival squamous cell carcinoma. Cornea. 2000;19(2):159-62. Epub 2000/04/04. PubMed PMID: 10746446.
  63. Moshfeghi DM, Moshfeghi AA, Finger PT. Enucleation. Survey of ophthalmology. 2000;44(4):277-301. Epub 2000/02/10. PubMed PMID: 10667436.
  64. Moshfeghi DM, Moshfeghi AA, Belafsky PC, Kim G, Sheffler M, Fink AJ, et al. Mardi Gras eye injury survey, 1998-1999. Southern medical journal. 2000;93(11):1083-6. Epub 2000/11/30. PubMed PMID: 11095558.
  65. Kazi AA, Peyman GA, Unal M, Khoobehi B, Yoneya S, Mori K, et al. Threshold power levels for NPe6 photodynamic therapy. Ophthalmic surgery and lasers. 2000;31(2):136-42. Epub 2000/04/01. PubMed PMID: 10743925.
  66. Peyman GA, Khoobehi B, Moshfeghi A, Sonmez M, Moshfeghi D, Shaibani S, et al. Blood velocity in an experimental iris tumor. Ophthalmic surgery and lasers. 1998;29(6):506-9. Epub 1998/06/26. PubMed PMID: 9640574.
  67. Peyman GA, Khoobehi B, Moshfeghi A, Moshfeghi D. Reversal of blood flow in experimental branch retinal vein occlusion. Ophthalmic surgery and lasers. 1998;29(7):595-7. Epub 1998/07/23. PubMed PMID: 9674011.
  68. Moshfeghi DM, Peyman GA, Moshfeghi AA, Khoobehi B, Primbs GB, Crean DH. Ocular vascular thrombosis following tin ethyl etiopurpurin (SnET2) photodynamic therapy: time dependencies. Ophthalmic surgery and lasers. 1998;29(8):663-8. Epub 1998/08/26. PubMed PMID: 9715492.
  69. Roth S, Rosenbaum PS, Osinski J, Park SS, Toledano AY, Li B, et al. Ischemia induces significant changes in purine nucleoside concentration in the retina-choroid in rats. Experimental eye research. 1997;65(6):771-9. Epub 1998/01/27. doi: 10.1006/exer.1997.0391. PubMed PMID: 9441700.
  70. Peyman GA, Moshfeghi DM, Moshfeghi A, Khoobehi B, Doiron DR, Primbs GB, et al. Photodynamic therapy for choriocapillaris using tin ethyl etiopurpurin (SnET2). Ophthalmic surgery and lasers. 1997;28(5):409-17. Epub 1997/05/01. PubMed PMID: 9150524.
  71. Roth S, Osinski JV, Park SS, ostwald P, Moshfeghi AA. Measurement of purine nucleoside concentration in the intact rat retina. Journal of neuroscience methods. 1996;68(1):87-90. Epub 1996/09/01. PubMed PMID: 8884617.
  72. Peyman GA, Moshfeghi DM, Moshfeghi AA, Khoobehi B. Fluorescent vesicle angiography with sodium fluorescein and indocyanine green. Ophthalmic surgery and lasers. 1996;27(4):279-84. Epub 1996/04/01. PubMed PMID: 8705742.
  73. Peyman GA, Moshfeghi DM, Moshfeghi A, Khoobehi B, Doiron DR, Crean DH, editors. Effect of light-activated tin ethyl etiopurpurin (SnET2) on normal rabbit choriocapillaries1996.
  74. Moshfeghi DM, Peyman GA, Moshfeghi AA, Crean DH, Khoobehi B. Early angiographic and histologic changes in choriocapillaris after photodynamic therapy. Investigative ophthalmology & visual science. 1996;37(3):S123.
  75. Moshfeghi AA, Serracarbassa PD, Calixto Jr. N, Khoobehi B, Peyman GA, Crean DH. Blood – retinal barrier integrity following systemic tin ethyl etiopurpurin (SnET2) administration. Investigative ophthalmology & visual science. 1996;37(3):S123.
  76. Crean DH, Peyman GA, Moshfeghi DM, Moshfeghi AA, Khoobehi B, Doiron DR. Photodynamic therapy response of choriocapillaris using tin ethyl etiopurpurin (SnET2). Investigative ophthalmology & visual science. 1996;37(3):S122.
  77. Roth S, Ostwald P, Goldstein I, Pachnanda A, Park S, Moshfeghi AA. Nitric oxide synthase inhibition, adenosine receptor blockade, and blood flow after retinal ischemia in cats. Neurosci Abstr. 1995;82:S387.
  78. Peyman GA, Moshfeghi AA, Moshfeghi DM, Khoobehi B. Fluorescent vesicle angiography with sodium fluorescein and indocyanine green. Investigative ophthalmology & visual science. 1995;36(4):S1040.
  79. Moshfeghi DM, Peyman GA, Khoobehi B, Moshfeghi AA, Crean D. Photodynamic occlusion of retinal vessels using tin ethyl etiopurpurin (SnET2): An efficacy study. Investigative ophthalmology & visual science. 1995;36(4):S115.
  80. Moshfeghi AA, Peyman GA, Fillacier K, Yang D, Khoobehi B. In vivo evaluation of an intravitreal sustained-release drug delivery device. Investigative ophthalmology & visual science. 1995;36(4):S617.
  81. Ribeiro RC, Peyman GA, Khoobehi B, Moshfeghi AA. Ocular toxicity of SnET2. Investigative ophthalmology & visual science. 1994;35(4):2221.
  82. Moshfeghi AA, Khoobehi B, Navarro G, Peyman GA. Optimal fluorescent dye concentrations for visualization of individual liposomes using SLO. Investigative ophthalmology & visual science. 1994;35(4):1401.